Atem Nebuliser Solution (Ipratropium Bromide) – Chiesi
CONTENTS:
Ipratropium Bromide 500mcg/UDV
FORM:
Unit Dose Vials (UDV’s)
INDICATIONS:
For the treatment of bronchial asthma, chronic obstructive bronchopneumopathy with asthmatic component.
Atem® 0.025% Nebuliser Solution
Each 2ml vial of Atem contains sterile Solution for nebulization – Ipratropium Bromide 500mcg Ipratropium bromide is a competitive antagonist of muscarinic acetylcholine receptors. It exhibits its greatest potency on bronchial receptors, whether given inhaled or through nebulizer but causes no tachycardia. No anticholinergic effects have been observed on cardiac function.
Reviews
There are no reviews yet.